Huichuang Medical Completes Over RMB 100 Million Series B Financing, Files Prospectus for IPO

36Kr learned that "Huichuang Medical" has completed over 100 million yuan in B-round financing, led by Zhongke Haichuang, with participation from Yida Capital, existing shareholder Qingyuan Investment, and Daoyuan Capital. This round of financing will be mainly used to further advance the brand building of the company's near-infrared (fNIRS) brain function imaging products and the clinical trials of transcranial light modulation therapy for degenerative diseases. Changhai Capital continues to serve as the exclusive financial advisor for the company's financing.Original Link